Authors
Loading...
This research reveals ALDH2's role in immunotherapy resistance in CRC, suggesting ARG2 as a target for enhancing immune checkpoint blockade.
Cai et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: